Company news
Tibet Rhodiola Pharmaceutical Holding Co. Class A (SSE:600211) news
Tibet Rhodiola Pharmaceutical Holding Co. Class A news releases on 6ix. Latest, Oct 26, 2024: Announcement on Convening Semi-annual and Q3 2024 Performance…
Press releases — page 2
Announcement on Convening Semi-annual and Q3 2024 Performance Briefing
October 25, 2024
Announcement on Obtaining Approval for Drug Supplement Application for Imdur (Chinese Market)
October 14, 2024
Announcement on Progress in Implementation of Significant Asset Restructuring
September 27, 2024
Announcement on the Implementation of 2024 Semi-annual Equity Distribution
August 21, 2024
Full Text of 2023 Semi-annual Report
August 13, 2024
Announcement on Progress in Implementation of Significant Assets Reorganization
June 28, 2024
Announcement on Result of Judicial Enforcement of Some Shares Held by Shareholder with Over 5% Shares
June 6, 2024